02.06.15
Plano, Texas-based Neuro Resource Group Inc. (NRG) has been awarded a U.S. patent for its self-directing, transcutaneous stimulation electrode.
The patented technology, which is imbedded in NRG’s new disposable electrodes, provides a design of alternating electrodes of both positive and negative polarities. These work with the company’s InterX 900 neurostimulation device to deliver pain management therapy to both in-patient post-surgical patients as well to patients in outpatient or home environments. According to the company, the electrode design and layout allows the electrodes to automatically locate and treat areas on the body of low impedance and provide more focused, higher amplitude stimulation, thus providing a more reliable and consistent pain management solution for a broad range of patient conditions.
“The issuance of our patent provides additional support and recognition to the uniqueness of InterX therapy and its overall capability to provide patients with improved non-drug, non-invasive therapy to manage both acute and chronic pain conditions,” said Dave Turner, NRG president and CEO.
Neuro Resource Group makes products for injury management, rehabilitation and pain management.
The patented technology, which is imbedded in NRG’s new disposable electrodes, provides a design of alternating electrodes of both positive and negative polarities. These work with the company’s InterX 900 neurostimulation device to deliver pain management therapy to both in-patient post-surgical patients as well to patients in outpatient or home environments. According to the company, the electrode design and layout allows the electrodes to automatically locate and treat areas on the body of low impedance and provide more focused, higher amplitude stimulation, thus providing a more reliable and consistent pain management solution for a broad range of patient conditions.
“The issuance of our patent provides additional support and recognition to the uniqueness of InterX therapy and its overall capability to provide patients with improved non-drug, non-invasive therapy to manage both acute and chronic pain conditions,” said Dave Turner, NRG president and CEO.
Neuro Resource Group makes products for injury management, rehabilitation and pain management.